Hajra Tily

990 total citations · 1 hit paper
7 papers, 799 citations indexed

About

Hajra Tily is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Hajra Tily has authored 7 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 3 papers in Immunology and 2 papers in Oncology. Recurrent topics in Hajra Tily's work include Systemic Lupus Erythematosus Research (5 papers), T-cell and B-cell Immunology (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Hajra Tily is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), T-cell and B-cell Immunology (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Hajra Tily collaborates with scholars based in United States. Hajra Tily's co-authors include András Perl, Maha Dawood, Stephen V. Faraone, Ricardo Garcı́a, Paul E. M. Phillips, Lisa Francis, Zhi‐Wei Lai, Ashwini Shadakshari, Ádám Bartos and Jianghong Yu and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hajra Tily

6 papers receiving 787 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

2018 320 citations Zhi‐Wei Lai, Ryan L. Kelly et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hajra Tily United States	4	489	380	236	106	76	7	799
Lianjie Shi China	15	425 0.9×	232 0.6×	216 0.9×	109 1.0×	48 0.6×	42	790
Nadia Alhashmi Oman	9	281 0.6×	233 0.6×	247 1.0×	59 0.6×	214 2.8×	15	678
Lisbeth Ärlestig Sweden	18	243 0.5×	424 1.1×	158 0.7×	81 0.8×	83 1.1×	31	721
Gongping Liang China	15	608 1.2×	230 0.6×	456 1.9×	149 1.4×	139 1.8×	18	1.1k
Phil Ruiz United States	10	536 1.1×	294 0.8×	262 1.1×	101 1.0×	66 0.9×	13	853
Kayaho Maeda Japan	13	410 0.8×	182 0.5×	224 0.9×	70 0.7×	64 0.8×	29	692
Katalin Tus United States	8	783 1.6×	360 0.9×	220 0.9×	132 1.2×	77 1.0×	10	1.0k
Vishala Chindalore United States	10	420 0.9×	484 1.3×	167 0.7×	162 1.5×	23 0.3×	17	835
Lesley Mason United Kingdom	14	427 0.9×	522 1.4×	149 0.6×	162 1.5×	49 0.6×	20	896
Kosuke Matsuo Japan	15	152 0.3×	165 0.4×	324 1.4×	61 0.6×	44 0.6×	27	637

Countries citing papers authored by Hajra Tily

Since Specialization

Citations

This map shows the geographic impact of Hajra Tily's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajra Tily with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajra Tily more than expected).

Fields of papers citing papers by Hajra Tily

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajra Tily. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajra Tily. The network helps show where Hajra Tily may publish in the future.

Co-authorship network of co-authors of Hajra Tily

This figure shows the co-authorship network connecting the top 25 collaborators of Hajra Tily. A scholar is included among the top collaborators of Hajra Tily based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajra Tily. Hajra Tily is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lai, Zhi‐Wei, Thomas Winans, Ashwini Shadakshari, et al.. (2022). 1203 Blockade of the mechanistic target of rapamycin elicits rapid and lasting improvement of disease activity through restraining pro-inflammatory T cell lineage specification in patients with active SLE. SHILAP Revista de lepidopterología. A86–A88.

2.

Lai, Zhi‐Wei, Ryan L. Kelly, Thomas Winans, et al.. (2018). Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial. The Lancet. 391(10126). 1186–1196. 320 indexed citations breakdown →

3.

Lai, Zhi‐Wei, Ashwini Shadakshari, Jianghong Yu, et al.. (2014). mTOR activation triggers proinflammatory expansion of IL-4-producing and necrosis-prone double-negative T cells, precedes flares, and serves as target for treatment in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 16(Suppl 1). A25–A25. 1 indexed citations

4.

Lai, Zhi‐Wei, Ashwini Shadakshari, Jianghong Yu, et al.. (2013). Mechanistic Target of Rapamycin Activation Triggers IL-4 Production and Necrotic Death of Double-Negative T Cells in Patients with Systemic Lupus Erythematosus. The Journal of Immunology. 191(5). 2236–2246. 123 indexed citations

5.

Lai, Zhi‐Wei, Robert Hanczko, Eduardo Bonilla, et al.. (2012). N ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial. Arthritis & Rheumatism. 64(9). 2937–2946. 328 indexed citations

6.

Tily, Hajra & András Perl. (2009). Lymphoedema: a paradoxical effect of tumour necrosis factor inhibitors – case report and review of literature. BMJ Case Reports. 2009. bcr0720080520–bcr0720080520. 3 indexed citations

7.

Rhew, Elisa Y., Chin Lee, Alan R. Dyer, et al.. (2008). Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus.. PubMed. 35(2). 230–6. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact